4.5 quarters of funding remaining and we expect FDA approval in 2025 before our reserves dip below 2 quarters.
We probably won't need to do another CR but, even if we do, it would be after FDA approval and at a much higher SP, well north of $2.
- Forums
- ASX - By Stock
- Ann: Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C
IMR
imricor medical systems inc.
Add to My Watchlist
3.80%
!
$1.52

4.5 quarters of funding remaining and we expect FDA approval in...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.52 |
Change
-0.060(3.80%) |
Mkt cap ! $487.0M |
Open | High | Low | Value | Volume |
$1.58 | $1.58 | $1.51 | $986.1K | 644.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 25000 | $1.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 8200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 1.530 |
1 | 2000 | 1.520 |
1 | 1500 | 1.510 |
3 | 25000 | 1.500 |
1 | 3000 | 1.490 |
Price($) | Vol. | No. |
---|---|---|
1.530 | 350 | 1 |
1.540 | 2564 | 1 |
1.650 | 6507 | 1 |
1.675 | 2000 | 1 |
1.710 | 5000 | 1 |
Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
Featured News
IMR (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online